Everest Organics Peer Comparison

Everest Organics Ltd. lags significantly behind its peers in almost all key financial metrics, showing no revenue growth, negative PE ratio, and poor profitability indicators. This reflects a challenging operational environment and raises concerns over its financial stability compared to other companies in the Pharmaceuticals & Drugs sector.

• • Everest Organics Ltd. has zero revenue growth and negative EPS, indicating lack of profitability and growth potential.
• • Sun Pharmaceutical Industries Ltd. leads in profitability metrics with a PE of 87.59 and ROE of 16.13%.
• • Dr. Reddy's Laboratories Ltd. ranks highest in terms of profitability while being attractively valued, making it a strong contender for investment.

• • Sun Pharmaceutical Industries Ltd.: Strong revenue growth and profitability with a PE ratio indicating investor confidence.
• • Dr. Reddy's Laboratories Ltd.: High ROE and low PE ratio suggest it is attractively valued with strong profitability.
• • Cipla Ltd.: Good balance of growth and profitability with a PEG ratio indicating potential for future growth.